These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10880898)

  • 21. Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: the Entred study 2001.
    Lecomte P; Romon I; Fosse S; Simon D; Fagot-Campagna A
    Diabetes Metab; 2008 Jun; 34(3):219-26. PubMed ID: 18343703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bipolar I disorder in France: prevalence of manic episodes and hospitalisation-related costs].
    de Zélicourt M; Dardennes R; Verdoux H; Gandhi G; Papatheodorou ML; Edgell ET; Khoshnood B; Chomette E; Even C; Fagnani F
    Encephale; 2003; 29(3 Pt 1):248-53. PubMed ID: 12876549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The costs of diabetes mellitus and its complications in Germany].
    Hauner H
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S240-2. PubMed ID: 17139578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Totally reimbursed care for type 2 diabetes in 1994: characteristics and follow-up].
    Vauzelle-Kervroëdan F; Cherou-Debregeas S; Forhan A; Fender P; Eschwège E
    Diabetes Metab; 2000 Sep; 26 Suppl 6():55-62. PubMed ID: 11011240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Costs of type II diabetes in the conditions of the Czech Republic's medical care system].
    Dolezal T; Písaríková Z; Zemanová P; Bartásková D
    Vnitr Lek; 2009 Apr; 55(4):342-4. PubMed ID: 19449746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What impact would pancreatic beta-cell preservation have on life expectancy, quality-adjusted life expectancy and costs of complications in patients with type 2 diabetes? A projection using the CORE Diabetes Model.
    Palmer AJ; Roze S; Valentine WJ; Minshall ME; Lammert M; Oglesby A; Hayes C; Spinas GA
    Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S59-66. PubMed ID: 15324517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Aterial hypertension and cardiovascular risk factors associated with diabetes. Report of the PHARE survey in general practice].
    Chamontin B; Lang T; Vaisse B; Nicodeme R; Antoine MP; Lazorthes ML; Gallois H; Poggi L
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):869-73. PubMed ID: 11575221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health care use and costs in the decade after identification of type 1 and type 2 diabetes: a population-based study.
    Johnson JA; Pohar SL; Majumdar SR
    Diabetes Care; 2006 Nov; 29(11):2403-8. PubMed ID: 17065675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Healthcare charges and utilization associated with diabetic neuropathy: impact of Type 1 diabetes and presence of other diabetes-related complications and comorbidities.
    Zhao Y; Ye W; Boye KS; Holcombe JH; Swindle R
    Diabet Med; 2009 Jan; 26(1):61-9. PubMed ID: 19125762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevalence and pharmacotherapy of diabetes mellitus in primary care].
    Lehnert H; Wittchen HU; Pittrow D; Bramlage P; Kirch W; Böhler S; Höfler M; Ritz E
    Dtsch Med Wochenschr; 2005 Feb; 130(7):323-8. PubMed ID: 15712019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The cost of diabetes in metropolitan France].
    Ricordeau P; Weill A; Vallier N; Bourrel R; Fender P; Allemand H
    Diabetes Metab; 2000 Sep; 26 Suppl 6():25-38. PubMed ID: 11011237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The socio-economic cost of diabetic complications in France.
    Triomphe A
    Diabet Med; 1991; 8 Spec No():S30-2. PubMed ID: 1825953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epidemiology, management and costs of type 2 diabetes in France in 1998].
    Detournay B; Vauzelle-Kervroedan F; Charles MA; Forhan A; Fagnani F; Fender P; Eschwege E
    Diabetes Metab; 1999 Sep; 25(4):356-65. PubMed ID: 10566128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a French experiment of team work between general practitioners and nurses on efficacy and cost of type 2 diabetes patients care.
    Mousquès J; Bourgueil Y; Le Fur P; Yilmaz E
    Health Policy; 2010 Dec; 98(2-3):131-43. PubMed ID: 20598768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Public financial support of research on diabetes in France].
    Mornex R
    Diabete Metab; 1993 Dec; 19(5 Suppl):500-2. PubMed ID: 8206186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prescriptions and consumption of venotonic drugs in France (à propos of the report of the French National Institute for prescriptions and consumption of drugs)].
    Bouvenot G
    Bull Acad Natl Med; 1999; 183(5):865-75; discussion 875-8. PubMed ID: 10464991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A rapid rise in the number of type-2 diabetics in kidney failure. Not just a problem of nephrologists].
    Ritz E; Lippert J; Keller C
    Dtsch Med Wochenschr; 1996 Oct; 121(41):1247. PubMed ID: 8925760
    [No Abstract]   [Full Text] [Related]  

  • 38. The cost of diabetes mellitus and its impact on health spending in Mexico.
    Villarreal-Ríos E; Salinas-Martínez AM; Medina-Jáuregui A; Garza-Elizondo ME; Núñez-Rocha G; Chuy-Díaz ER
    Arch Med Res; 2000; 31(5):511-4. PubMed ID: 11179587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of type 2 diabetes on health expenditure: estimation based on individual administrative data.
    Baudot FO; Aguadé AS; Barnay T; Gastaldi-Ménager C; Fagot-Campagna A
    Eur J Health Econ; 2019 Jul; 20(5):657-668. PubMed ID: 30612221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cost of diabetes in France.
    Triomphe A; Flori YA; Costagliola D; Eschwege E
    Health Policy; 1988; 9(1):39-48. PubMed ID: 10286665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.